Early glycemia and mortality in critically ill septic patients: Interaction with insulin‐treated diabetes

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of critical care

• Publication date

  2018-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcrc.2018.03.012PMID 29544173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Long and Winding Road Toward Personalized Glycemic Control in the Critically Ill

  2018cited by this paper
• SAFETY AND EFFICACY OF PERSONALIZED GLYCEMIC CONTROL IN CRITICALLY ILL PATIENTS: A 2-YEAR BEFORE AND AFTER INTERVENTIONAL TRIAL.

  2017cited by this paper
• Diabetes Is Not Associated With Increased 90-Day Mortality Risk in Critically Ill Patients With Sepsis

  2017cited by this paper
• A minimum blood glucose value less than or equal to 120 mg/dL under glycemic control is associated with increased 14-day mortality in nondiabetic intensive care unit patients with sepsis and stress hyperglycemia.

  2016cited by this paper
• Acute severe illness in diabetes patients: is tolerating hyperglycemia beneficial?

  2016cited by this paper
• Dysglycemia and Glucose Control During Sepsis.

  2016influential reference
• Liberal Versus Conventional Glucose Targets in Critically Ill Diabetic Patients: An Exploratory Safety Cohort Assessment

  2016cited by this paper
• Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study

  2016cited by this paper
• Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality

  2016cited by this paper
• The ANZROD model: better benchmarking of ICU outcomes and detection of outliers.

  2016cited by this paper
• Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults

  2015cited by this paper
• The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

  2015cited by this paper
• Systemic inflammatory response syndrome criteria in defining severe sepsis.

  2015cited by this paper
• Glycemic Variability: How Do We Measure It and Why Is It Important?

  2015cited by this paper
• Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.

  2014cited by this paper
• Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality

  2014cited by this paper
• Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study

  2013cited by this paper
• Risk prediction of hospital mortality for adult patients admitted to Australian and New Zealand intensive care units: development and validation of the Australian and New Zealand Risk of Death model.

  2013cited by this paper
• Stress hyperglycemia: an essential survival response!

  2013influential reference
• Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: a translational study

  2013cited by this paper
• The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients

  2012cited by this paper
• The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes*

  2011cited by this paper
• Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis

  2010cited by this paper
• Hypoglycemia and outcome in critically ill patients.

  2010cited by this paper
• Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.

  2010cited by this paper
• Hyperglycemia–related mortality in critically ill patients varies with admission diagnosis*

  2009cited by this paper
• The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study

  2009cited by this paper
• Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness.

  2009cited by this paper
• Stress hyperglycaemia.

  2009cited by this paper
• Blood Glucose Variability is Associated with Mortality in the Surgical Intensive Care Unit

  2008cited by this paper
• Blood glucose concentration and outcome of critical illness: The impact of diabetes*

  2008cited by this paper
• Normalization of glucose in the intensive care unit: does one size really fit all?

  2008cited by this paper
• Blood glucose on day of intensive care unit admission as a surrogate of subsequent glucose control in intensive care.

  2006cited by this paper
• Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients

  2006cited by this paper
• Development and implementation of a high-quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient Database.

  2006influential reference
• Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital.

  2006cited by this paper
• Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus.

  2005cited by this paper
• Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units

  2004influential reference
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper
• Stress hyperglycaemia.

  1984cited by this paper

• Impact of streptozotocin (STZ)-induced hyperglycemia on the host response to sepsis.

  2025cites this paper
• Combined Analysis of Transcriptome and Mendelian Randomization Reveals AKT1 and PPARG as Biomarkers Related to Glucose Metabolism in Sepsis

  2025cites this paper
• Evaluation of NPH Insulin Dosing Interval for Critically Ill Hyperglycemic Trauma Patients During Continuous Enteral Nutrition: A Pilot Study

  2025cites this paper
• Critical care nutrition and the legacy of Rinaldo Bellomo

  2025cites this paper
• Sepsis-associated encephalopathy: Unraveling molecular mechanisms, emerging therapeutics, and translational frontiers.

  2025cites this paper
• Association between stress hyperglycemia ratio and all-cause mortality in critically ill patients with sepsis: results from the MIMIC-IV database

  2025cites this paper
• A retrospective analysis of the correlation between the glucose-to-albumin ratio and 28-day mortality in sepsis patients

  2025cites this paper
• Intelligent Prediction Platform for Sepsis Risk Based on Real-Time Dynamic Temporal Features: Design Study

  2025cites this paper
• Outpatient diabetes management influences glycemic control for critically ill patients during nutrition support: A retrospective observational study.

  2024cites this paper
• Identification and experimental validation of diagnostic and prognostic genes CX3CR1, PID1 and PTGDS in sepsis and ARDS using bulk and single-cell transcriptomic analysis and machine learning

  2024cites this paper
• Value of modified qSOFA, glucose and lactate in predicting prognosis in children with sepsis in the PICU

  2024cites this paper
• Exploiting Electronic Data to Advance Knowledge and Management of Severe Infections

  2023cites this paper
• Hypoglycemic Agents and Anesthetic Techniques to Ameliorate Stress Hyperglycemia in Critically Ill Patients: A Systematic Review

  2023cites this paper
• Positionspapier: Operation und Diabetes mellitus (Update 2023)

  2023cites this paper
• The association between hypoglycemia and mortality in sepsis and septic shock: A systematic review and meta-analysis.

  2023cites this paper
• Hypoglycemia: Elucidating its circadian propensity and recovery time based on clinical parameters

  2022cites this paper
• The prognostic value of N-terminal pro-brain natriuretic peptide (NT-proBNP) in major burn patients with sepsis.

  2022cites this paper
• Association of Blood Glucose Level and Glycemic Variability With Mortality in Sepsis Patients During ICU Hospitalization

  2022cites this paper
• A comparison of arterial blood glucose and peripheral blood glucose levels in critically ill patients: measurements using the arterial blood gas analyzer and the rapid glucose meter.

  2021cites this paper
• Application of Peak Glucose Range and Diabetes Status in Mortality Risk Stratification in Critically Ill Patients with Sepsis

  2021cites this paper
• Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study

  2021cites this paper
• Novel Relationship Between Hemoglobin A1c Levels and Foot Ulcer Development Among Patients With Type 2 Diabetes Mellitus Admitted at Tupua Tamasese Meaole Hospital

  2021cites this paper
• Hypoglycemia and mortality in sepsis patients: A systematic review and meta-analysis.

  2021cites this paper
• Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis

  2020cites this paper
• Mean amplitude of glycemic excursions in septic patients and its association with outcomes: A prospective observational study using continuous glucose monitoring.

  2020cites this paper
• Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis

  2020cites this paper
• Positionspapier: Operation und Diabetes mellitus (Update 2019)

  2019cites this paper
• Is it time to abandon glucose control in critically ill adult patients?

  2019cites this paper
• Updates in Glycemic Management in the Hospital

  2019cites this paper
• DIABETES STATUS IMPACTS THE RELATIONSHIP BETWEEN GLYCEMIC CONTROL IN THE CRITICALLY ILL AND MORTALITY

  2019cites this paper
• RELATIONSHIP BETWEEN HIGH SERUM GLUCOSE LEVEL IN PATIENTS WHO ARE CRITICALLY ILL AND MORTALITY RATE

  2018cites this paper